Clinical trial
Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate…
NCT00459810 · OHSU Knight Cancer Institute, Other · Terminated
Key facts
| NCT number | NCT00459810 |
|---|---|
| Title | Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer |
| Official title | A Phase II Study of Paclitaxel Poliglumex (PPX) in Combination With Transdermal Estradiol for the Treatment of Androgen Independent Prostate Cancer After Docetaxel Chemotherapy |
| Lead sponsor | OHSU Knight Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | transdermal estradiol, paclitaxel poliglumex |
| Enrollment | 21 |
| Start date | Feb 1, 2007 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Apr 13, 2007 |
| Last update posted | Apr 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: